Skip to main content
Equibles

LEGN · Legend Biotech Corp · Metrics

Track LEGN — free

Use LEGN with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research LEGN.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$18.80 +0.17 (+0.91%)
Rebalance outlook locked
Market Cap
$3.62B
Shares
194.49M
Volume · Oct 22 393.63K Avg daily vol (3M) 2.3M

LEGN metrics

67 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$18.63
Market cap
$3.62B

Price action

20 metrics
Price change (1W)
+6.3%
Price change (30D)
+2.6%
Price change (3M)
-19.2%
Price change (6M)
-24.6%
Price change (YTD)
-12.6%
Price change (1Y)
-42.2%
Trailing year
Price change (5Y)
-65.1%
52-week high
$36.28
52-week low
$16.65
Change from 52-week high
-47.6%
Change from 52-week low
+14.2%
Annualized volatility
75.1%
Annualized volatility (3M)
58.0%
Beta
0.5
RSI (14D)
50.0
Price vs SMA 50
-3.2%
Price vs SMA 200
-14.4%
Avg volume (3M)
2.31M
Relative volume
0.5
Average dollar volume
$45.37M

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
194.49M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
2.9×
reciprocal yield 34.4%
P / book
3.0
reciprocal yield 33.3%
FCF yield
-3.3%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
—

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-11

Profitability

9 metrics
Gross margin
57.2%
Operating margin
-4.3%
Trailing 12 months
Net margin
—
Gross profit (TTM)
$727.30M
Operating profit (TTM)
−$55.00M
Net income (TTM)
−$218.15M
Trailing 12 months
Diluted EPS (TTM)
$-0.52
FCF margin
-9.6%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$5.42

Growth

11 metrics
Revenue growth YoY
+51.9%
Year over year
Net income growth YoY
—
Revenue (TTM)
$1.27B
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+1.0%
Year over year · more shares
Revenue CAGR (3Y)
+106.4%
Revenue CAGR (5Y)
+68.8%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-21.4%
Return on assets
-13.5%
Debt / equity
—
Current ratio
3.0
EBITDA (TTM)
—
Free cash flow (TTM)
−$121.80M
Quick ratio
2.9
Interest coverage
-2.5
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$672.90M
Total assets
$1.75B
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$89.40M
Capital expenditures (TTM)
$32.40M
R&D (TTM)
$396.20M
SG&A (TTM)
—
Stock compensation (TTM)
—
R&D / revenue
31.2%
Stock compensation / revenue
—

Ownership (13F)

9 metrics
13F filers
221
13F filer change QoQ
+28
Institutional ownership
53.5%
Conviction holders (share of 13F filers)
5.5%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
+4.4%
Holder tenure
15.3
Price vs estimated holder cost
-13.4%

Ownership (registered funds)

1 metrics
Index-fund ownership
1.8%

Short interest

3 metrics
Short interest
8.4%
Latest settlement · 7.1 days to cover
Days to cover
7.1d
Short-squeeze score
71 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$308,550
Insider-sentiment score
36 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1801198 CUSIP 52490G102 13F (30d) 14 filings 14 filers Visit website Investor relations